Nizar Abuharfeil received his PhD in Microbiology/Medical Virology from Manchester University, Manchester-UK in December 1991. During his PhD, he worked on the development of synthetic vaccine from measles virus. He prepared 8 synthetic peptides from the hemagglutinin and fusion proteins of the measles virus to be used as a vaccine for measles virus for the benefit of Proteus Biotechnology Ltd., UK.
Biotechnology